Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 05, 2020 15:35 ET | Source: OPKO Health, Inc.

OPKO Health to Participate in BTIG Virtual Biotechnology Conference

MIAMI, Aug. 05, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that management will participate in a fireside chat at the BTIG Virtual Biotechnology Conference on Monday,...
July 30, 2020 16:05 ET | Source: OPKO Health, Inc.

OPKO Health Reports 2020 Second Quarter Business Highlights and Financial Results

MIAMI , July 30, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended June 30, 2020. Second Quarter Business...
July 27, 2020 08:00 ET | Source: OPKO Health, Inc.

OPKO Health to Report Second Quarter 2020 Financial Results on July 30, 2020

MIAMI, July 27, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended June 30, 2020, as well as discuss financial...
June 09, 2020 08:00 ET | Source: OPKO Health, Inc.

OPKO Health Announces Positive Top-Line Results of Phase 3 Efficacy and Safety Study of Somatrogon for the Treatment of Japanese Children with Growth Hormone Deficiency

MIAMI, June 09, 2020 (GLOBE NEWSWIRE) -- Following last October’s announcement of successful results of the global Phase 3 study of once-weekly somatrogon, an investigational agent for the treatment...
June 01, 2020 08:00 ET | Source: OPKO Health, Inc.

FDA Authorizes OPKO Health Clinical Trial Evaluating RAYALDEE in COVID-19 Patients

MIAMI, June 01, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that the U.S. Food and Drug Administration (FDA) has authorized OPKO to undertake a Phase 2 trial with...
May 27, 2020 08:00 ET | Source: OPKO Health, Inc.

OPKO Health to Present at the Jefferies Virtual Healthcare Conference

MIAMI, May 27, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announced today that management will be participating in the Jefferies Virtual Healthcare Conference being held June 2-4,...
May 06, 2020 16:05 ET | Source: OPKO Health, Inc.

OPKO Health Reports 2020 First Quarter Business Highlights and Financial Results

MIAMI, May 06, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended March 31, 2020. Business Highlights ...
April 30, 2020 16:05 ET | Source: OPKO Health, Inc.

OPKO Health to Report First Quarter 2020 Financial Results on May 6, 2020

MIAMI, April 30, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2020, as well as discuss financial...
April 22, 2020 08:00 ET | Source: OPKO Health, Inc.

Somatrogon Phase 3 Pediatric Trial Results will be presented on June 8 at ENDO Online 2020

MIAMI, April 22, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today provided an update on two abstracts regarding the global Phase 3 somatrogon pediatric trial evaluating somatrogon...
March 25, 2020 08:00 ET | Source: OPKO Health, Inc.

OPKO Health Reports Interim Results for Two Ongoing RAYALDEE Studies

Phase 4 Head-to-Head Study in Patients with Stage 3 or 4 Chronic Kidney Disease Phase 2 Trial in Patients with Stage 5 Chronic Kidney Disease on Dialysis MIAMI, March 25, 2020 (GLOBE NEWSWIRE) --...